THE USE OF THE HUMAN SAPHENOUS-VEIN IN PHARMACOLOGY

被引:22
作者
DOCHERTY, JR
机构
关键词
D O I
10.1016/0165-6147(87)90147-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:358 / 361
页数:4
相关论文
共 20 条
[1]   PROPOSALS FOR THE CLASSIFICATION AND NOMENCLATURE OF FUNCTIONAL RECEPTORS FOR 5-HYDROXYTRYPTAMINE [J].
BRADLEY, PB ;
ENGEL, G ;
FENIUK, W ;
FOZARD, JR ;
HUMPHREY, PPA ;
MIDDLEMISS, DN ;
MYLECHARANE, EJ ;
RICHARDSON, BP ;
SAXENA, PR .
NEUROPHARMACOLOGY, 1986, 25 (06) :563-576
[2]   IN-VITRO DEMONSTRATION OF EXISTENCE OF BETA-ADRENOCEPTORS IN HUMAN SAPHENOUS AND CANINE FEMORAL VEINS [J].
BUCHER, TJ ;
MULLERSC.E ;
STURMER, E .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1973, 280 (02) :153-160
[3]   EFFECT OF ISOPRENALINE ON ADRENOCEPTORS IN HUMAN SAPHENOUS VEIN [J].
COUPAR, IM .
BRITISH JOURNAL OF PHARMACOLOGY, 1970, 39 (03) :465-&
[4]   NO EVIDENCE FOR DIFFERENCES BETWEEN PRE-JUNCTIONAL AND POST-JUNCTIONAL ALPHA-2-ADRENOCEPTORS [J].
DOCHERTY, JR ;
HYLAND, L .
BRITISH JOURNAL OF PHARMACOLOGY, 1985, 86 (02) :335-339
[5]   AN EXAMINATION OF 5-HYDROXYTRYPTAMINE RECEPTORS IN HUMAN SAPHENOUS-VEIN [J].
DOCHERTY, JR ;
HYLAND, L .
BRITISH JOURNAL OF PHARMACOLOGY, 1986, 89 (01) :77-81
[6]   VASCULAR ALPHA-2-ADRENOCEPTORS CAN MEDIATE NERVE STIMULATION-EVOKED CONTRACTIONS [J].
DOCHERTY, JR ;
HYLAND, L .
CLINICAL SCIENCE, 1985, 68 :S117-S120
[7]   EVIDENCE FOR NEURO-EFFECTOR TRANSMISSION THROUGH POSTJUNCTIONAL ALPHA-2-ADRENOCEPTORS IN HUMAN SAPHENOUS-VEIN [J].
DOCHERTY, JR ;
HYLAND, L .
BRITISH JOURNAL OF PHARMACOLOGY, 1985, 84 (02) :573-576
[8]  
FLAVAHAN NA, 1984, J PHARMACOL EXP THER, V230, P699
[9]   INHIBITORY PRESYNAPTIC 5-HYDROXYTRYPTAMINE (5-HT) RECEPTORS ON THE SYMPATHETIC-NERVES OF THE HUMAN SAPHENOUS-VEIN [J].
GOTHERT, M ;
KOLLECKER, P ;
ROHM, N ;
ZERKOWSKI, HR .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1986, 332 (04) :317-323
[10]   MODULATION OF NORADRENALINE RELEASE IN HUMAN SAPHENOUS-VEIN VIA PRESYNAPTIC ALPHA-2-ADRENOCEPTORS [J].
GOTHERT, M ;
SCHLICKER, E ;
HENTRICH, F ;
ROHM, N ;
ZERKOWSKI, HR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 102 (02) :261-267